Survival curves according to response in all patients. (A) PFS in patients achieving CR, VGPR, and PR. (B) OS in patients achieving CR, VGPR, and PR. (C) Landmark analysis of PFS (landmark point at 6 months) in patients achieving CR, VGPR, and PR. (D) Landmark analysis of OS (landmark point at 6 months) in patients achieving CR, VGPR, and PR.